2006 Annual Meeting | Child Neurology

Date Monday 04/03/06

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) James J. Riviello, Jr., MD

Topic(s)

Learning Objectives Upon Completion:
Participants should be able to incorporate newer diagnostic and therapeutic approaches into the management of these categories of neurological disorders occurring in children and adolescents and should be aware of the practice parameters that apply.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
09:00 AM - 09:40 AM		Hypotonia and Neuromuscular Disorders Basil T. Darras, MD
09:40 AM - 10:20 AM		Benign Epilepsies Deepak K. Lachhwani, MD, FAAN, Elaine Wyllie, MD
10:20 AM - 10:35 AM		Break
10:35 AM - 11:15 AM		Movement Disorders Harvey S. Singer, MD, FAAN
11:15 AM - 11:55 AM		Headache Robert S. Rust, MD
11:55 AM - 12:05 PM		Questions and Answers
12:05 PM - 01:00 PM		Lunch
01:00 PM - 01:45 PM		Neurobehavioral Disorders and Autism David K. Urion, MD, FAAN
01:45 PM - 02:30 PM		Neonatal Neurology Janet S. Soul, MD
02:30 PM - 03:10 PM		Inborn Errors of Metabolism Marc C. Patterson, MD, FRACP, FAAN
03:10 PM - 03:25 PM		Break
03:25 PM - 04:05 PM		Malignant Epilepsies and Refractory Seizures Edwin Trevathan, MD, MPH, FAAN
04:05 PM - 04:45 PM		Neurological Emergencies James J. Riviello, Jr., MD
04:45 PM - 05:00 PM		Questions and Answers

Faculty Disclosures
James J. Riviello, Jr., MD	Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for J. Kiffin Penry Foundation. An immediate family member of Dr. Riviello has received publishing royalties from a publication relating to health care. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Utah. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Calgary.
Harvey S. Singer, MD, FAAN	No disclosure on file
Edwin Trevathan, MD, MPH, FAAN	Dr. Trevathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. The institution of Dr. Trevathan has received research support from NINDS/NIH.
David K. Urion, MD, FAAN	Dr. Urion has nothing to disclose.
Elaine Wyllie, MD	Dr. Wyllie has received publishing royalties from a publication relating to health care.
Robert S. Rust, MD	No disclosure on file
Marc C. Patterson, MD, FRACP, FAAN	Dr. Patterson has received personal compensation for serving as an employee of IntraBio. The institution of Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme /KemPharm/Zevra. Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azafaros. Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IntraBio. Dr. Patterson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage. Dr. Patterson has stock in IntraBio. The institution of Dr. Patterson has received research support from Glycomine. The institution of Dr. Patterson has received research support from Orphazyme /KemPharm/Zevra. The institution of Dr. Patterson has received research support from Idorsia. The institution of Dr. Patterson has received research support from Shire-Takeda. Dr. Patterson has received publishing royalties from a publication relating to health care. Dr. Patterson has received publishing royalties from a publication relating to health care.
Basil T. Darras, MD	The institution of Dr. Darras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Darras has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. The institution of Dr. Darras has received research support from National Institutes of Health/National Institute of Neurological Disorders and Stroke,. The institution of Dr. Darras has received research support from Slaney Family Fund for SMA. The institution of Dr. Darras has received research support from Spinal Muscular Atrophy Foundation. The institution of Dr. Darras has received research support from CureSMA. The institution of Dr. Darras has received research support from Working on Walking Fund . The institution of Dr. Darras has received research support from CHERISH, CS2/CS12 . The institution of Dr. Darras has received research support from Biogen for CS11. The institution of Dr. Darras has received research support from AveXis. The institution of Dr. Darras has received research support from Sarepta Pharmaceuticals. The institution of Dr. Darras has received research support from PTC Therapeutics. The institution of Dr. Darras has received research support from Roche. The institution of Dr. Darras has received research support from Santhera. The institution of Dr. Darras has received research support from Scholar Rock. The institution of Dr. Darras has received research support from Fibrogen. The institution of Dr. Darras has received research support from Summit. Dr. Darras has received publishing royalties from a publication relating to health care. Dr. Darras has received publishing royalties from a publication relating to health care.
Janet S. Soul, MD	The institution of Dr. Soul has received research support from UCB. Dr. Soul has received publishing royalties from a publication relating to health care.
Deepak K. Lachhwani, MD, FAAN	The institution of Dr. Lachhwani has received research support from ICON Clinical Research LLC.

��ɫ��

��ɫ��